NCM

Nantahala Capital Management Portfolio holdings

AUM $1.6B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+121.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.68B
AUM Growth
+$58.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
160
New
Increased
Reduced
Closed

Top Buys

1
+$49.8M
2
+$28.8M
3
+$27.8M
4
SLNO
Soleno Therapeutics
SLNO
+$24.7M
5
PTON icon
Peloton Interactive
PTON
+$15.7M

Top Sells

1
+$59.5M
2
+$44.1M
3
+$35.3M
4
AMRX icon
Amneal Pharmaceuticals
AMRX
+$20.3M
5
IMAX icon
IMAX
IMAX
+$18.1M

Sector Composition

1 Healthcare 62.18%
2 Consumer Discretionary 15.78%
3 Financials 6.34%
4 Communication Services 5.5%
5 Industrials 2.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPRX icon
126
Kiora Pharmaceuticals
KPRX
$11.9M
$209K 0.01%
106,156
-50,271
NUVB.WS
127
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$207K 0.01%
+626,191
APRE icon
128
Aprea Therapeutics
APRE
$9.44M
$176K 0.01%
205,760
LUCD icon
129
Lucid Diagnostics
LUCD
$192M
$103K 0.01%
94,541
CNTX icon
130
Context Therapeutics
CNTX
$187M
$55.6K ﹤0.01%
37,837
-1,624,113
GFAIW icon
131
Guardforce AI Warrant
GFAIW
$145K
$23.1K ﹤0.01%
154,205
PERF.WS
132
DELISTED
Perfect Corp Warrants
PERF.WS
$323 ﹤0.01%
16,075
AGIO icon
133
Agios Pharmaceuticals
AGIO
$1.71B
– –
-100,000
ALGN icon
134
Align Technology
ALGN
$11.6B
– –
0
ANIK icon
135
Anika Therapeutics
ANIK
$192M
– –
-20,961
AQST icon
136
Aquestive Therapeutics
AQST
$506M
– –
-600,000
CYTK icon
137
Cytokinetics
CYTK
$9.6B
– –
-150,000
CZR icon
138
Caesars Entertainment
CZR
$5.94B
– –
-98,879
DCTH icon
139
Delcath Systems
DCTH
$357M
– –
-666,435
DYN icon
140
Dyne Therapeutics
DYN
$2.97B
– –
-702,884
ELDN icon
141
Eledon Pharmaceuticals
ELDN
$269M
– –
-1,141,237
EVOK
142
DELISTED
Evoke Pharma
EVOK
– –
-148,153
EW icon
143
Edwards Lifesciences
EW
$49.5B
– –
0
GPCR icon
144
Structure Therapeutics
GPCR
$2.78B
– –
-368,553
HOOD icon
145
Robinhood
HOOD
$79.5B
– –
0
KOD icon
146
Kodiak Sciences
KOD
$2.14B
– –
-290,884
SCPH
147
DELISTED
scPharmaceuticals
SCPH
– –
-861,277
TEVA icon
148
Teva Pharmaceuticals
TEVA
$40.1B
– –
0
VTGN icon
149
VistaGen Therapeutics
VTGN
$22.8M
– –
-1,978,492
VTRS icon
150
Viatris
VTRS
$18.5B
– –
0
3 4 5
6
7